|
시장보고서
상품코드
2051298
의약품 정밀화학 시장 : 종류별, 제품 유형별, 용도별, 지역별Pharmaceutical Fine Chemicals Market, By Type, By Product, By Application, By Geography |
||||||
의약품 정밀화학 시장은 2026년에 1,477억 4,000만 달러로 추정되며, 2033년까지 2,581억 7,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 8.3%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 1,477억 4,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 8.30% | 2033년 시장 규모 예측: | 2,581억 7,000만 달러 |
의약품 정밀화학 시장은 최근 몇 년 동안 괄목할 만한 성장을 이루었습니다. 의약품 정밀화학이란 의약품 제제에 사용되는 유효성분(API) 또는 원료를 말합니다. 만성질환 유병률 증가, 고령화 진행, 바이오제약 기업의 의약품 개발에 대한 연구개발 투자 확대 등의 요인으로 인해 제약용 정밀화학제품에 대한 수요가 증가하고 있습니다. 또한, 맞춤형 합성 및 제조 서비스는 제약 제조업체가 비용을 최적화하고 다른 활동에 집중할 수 있도록 지원하기 위해 주목을 받고 있습니다. 또한, 의약품 유효성분 제조업체와 제제업체 간 체결되는 장기 공급 계약도 의약품 정밀화학 시장의 성장을 견인하고 있습니다. 그러나 엄격한 규제 프레임워크와 의약품 개발 프로세스에 따른 높은 비용은 시장 성장을 촉진하는 데 있어 장애요인으로 작용하고 있습니다. 전반적으로, 세계 의약품 정밀화학 시장은 향후 몇 년 동안 유망한 기회를 제시할 것으로 예상됩니다.
시장 역학
의약품 정밀화학 시장은 만성질환에 취약한 세계 인구의 고령화, 의료비 증가, 생활습관병 유병률 증가 등의 요인에 의해 주도되고 있습니다. 유엔에 따르면, 2050년까지 전 세계 인구 6명 중 1명이 65세 이상이 될 것으로 예측하고 있습니다. 또한, 제약기업의 의약품 개발에 대한 연구개발비 증가와 위탁생산의 도입이 시장 성장을 견인하고 있습니다. 그러나 시장은 의약품 승인에 대한 엄격한 규제 환경과 의약품 제조에 따른 높은 비용이라는 도전에 직면해 있습니다. 한편, API(원료의약품) 제조 공정에서 수탁 합성 및 제조의 확대는 이해관계자들에게 큰 기회를 가져다주고 있습니다. 또한, 저비용의 숙련된 인력을 보유한 신흥 시장으로의 API 제조 아웃소싱은 시장 관계자들에게 새로운 길을 열어주고 있습니다.
본 조사의 주요 특징
- 이 조사에서는 각 부문의 잠재적인 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 조사는 다음과 같은 매개 변수를 기반으로 세계 제약용 정밀화학 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 세계 의약품 정밀화학 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
목차
제1장 조사 목적과 가정
제2장 시장 개요
제3장 시장 역학·규제·동향 분석
제4장 의약품 정밀화학 시장 : 유형별, 2026-2033년
제5장 의약품 정밀화학 시장 : 제품별, 2026-2033년
제6장 의약품 정밀화학 시장 : 용도별, 2026-2033년
제7장 의약품 정밀화학 시장 : 지역별, 2026-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.16Pharmaceutical Fine Chemicals Market is estimated to be valued at USD 147.74 Bn in 2026 and is expected to reach USD 258.17 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 147.74 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 8.30% | 2033 Value Projection: | USD 258.17 Bn |
The pharmaceutical fine chemicals market has been witnessing significant growth over the past few years. Pharmaceutical fine chemicals refer to active pharmaceutical ingredients or bulk drug substances which are used in pharmaceutical formulations. Factors, such as rising prevalence of chronic diseases, increasing elderly population, and growing research and development investments in drug development by biopharmaceutical companies, are fueling the demand for pharmaceutical fine chemicals. Furthermore, custom synthesis and manufacturing services are gaining traction as they help drug manufacturers optimize costs and focus on other core activities. Various agreements between Active Pharmaceutical Ingredients makers and drug formulation businesses for long term supply are also propelling the pharmaceutical fine chemicals market. However, stringent regulatory framework and high costs associated with drug development processes pose challenges to boost the market growth. Overall, the global pharmaceutical fine chemicals market is anticipated to showcase lucrative opportunities in the coming years.
Market Dynamics
The pharmaceutical fine chemicals market is driven by factors such as growing geriatric population globally prone to chronic diseases, rising healthcare expenditure, and increasing incidence of lifestyle diseases. As per the United Nations, by 2050, one in six people in the world will be over age 65. Furthermore, increasing R&D spending on drug development by pharmaceutical companies and the adoption of contract manufacturing are fueling the market growth. However, the market faces challenges from stringent regulatory environment for drug approval and high costs associated with drug manufacturing. On the other hand, the growing adoption of custom synthesis and manufacturing in the API production process presents significant opportunities for stakeholders. Additionally, outsourcing of API manufacturing to emerging markets with low-cost skilled labor is opening new avenues for market players.
Key features of the study
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global pharmaceutical fine chemicals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Denisco, Albemarle Corporation, Kenko Corporation, GRACE, CHEMADA, JMP Statistical Discovery LLC., Pfizer Inc., GSK plc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global pharmaceutical fine chemicals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
- Pharmaceutical Fine Chemicals Market, By Type (Revenue, USD Bn, 2021 - 2033)
- Proprietary
- Non-Proprietary
- Pharmaceutical Fine Chemicals Market, By Product (Revenue, USD Bn, 2021 - 2033)
- Basic Building Blocks
- Advanced Intermediates
- Active Ingredients
- Pharmaceutical Fine Chemicals Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Cardiovascular
- Neurological
- Oncological
- Infectious Diseases
- Metabolic System
- Diabetes
- Respiratory
- Gastrointestinal
- Musculoskeletal
- Others
- Pharmaceutical Fine Chemicals Market, By Region (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Top companies in the pharmaceutical fine chemicals market
- Denisco
- Albemarle Corporation
- Kenko Corporation
- GRACE
- CHEMADA
- JMP Statistical Discovery LLC.
- Pfizer Inc.
- GSK plc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Type
- Market Snippet, By Product
- Market Snippet, By Application
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Rising Demand for Biosimilars
- Increasing Government Healthcare Spending
- Restraints
- Regulatory Compliance Increasing Production Costs
- Capacity Limitations Restricting Output
- Opportunities
- Outsourcing of Fine Chemicals Production
- Growth in Biologics and Biosimilars Market
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Pharmaceutical Fine Chemicals Market, By Type, 2026 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Proprietary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Non-Proprietary
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
5. Pharmaceutical Fine Chemicals Market, By Product, 2026 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Basic Building Blocks
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Advanced Intermediates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Active Ingredients
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
6. Pharmaceutical Fine Chemicals Market, By Application, 2026 - 2033 (USD Bn)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Neurological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Oncological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Metabolic System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Gastrointestinal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Mucoskeletal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Bn)
7. Pharmaceutical Fine Chemicals Market, By Region, 2026 - 2033 (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2026 - 2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033,(USD Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033,(USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033,(USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- Asean
- Rest Of Asia Pacific
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033,(USD Bn)
- GCC
- Israel
- Rest of Middle East
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2026 - 2033,(USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033,(USD Bn)
- Mexico
- Argentina
- Brazil
8. Competitive Landscape
- Company Profiles
- Denisco
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Albemarle Corporation
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Kenko Corporation
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GRACE
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- CHEMADA
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- JMP Statistical Discovery LLC.
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Pfizer Inc.
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- GSK plc
- Company Highlights
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Denisco
- Analyst Views
9. Section
- Research Methodology
- About us
